Swiss Life Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Buy
12,587
+122
+1% +$2.78K ﹤0.01% 1226
2026
Q1
$267K Buy
12,465
+1,724
+16% +$35.9K ﹤0.01% 1196
2025
Q4
$230K Buy
+10,741
New +$220K ﹤0.01% 1197
2017
Q3
Sell
-17,350
Closed -$1.05M 496
2017
Q2
$1.05M Buy
17,350
+1,569
+10% +$93K 0.03% 321
2017
Q1
$1.1M Buy
+15,781
New +$1.1M 0.03% 261

Other funds holding MD

Swiss Life Asset Management's MD Position: Q2 2026 in Review

Swiss Life Asset Management increased its Pediatrix Medical (MD) stake by 0.98% in Q2 2026, buying an estimated $2.78K and bringing the position to 12,587 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Swiss Life Asset Management first reported a position in MD in Q1 2017 and has held it in 5 quarters since. The position peaked at $1.1M in Q1 2017. 197 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Swiss Life Asset Management held 12,587 shares of Pediatrix Medical worth $319K as of Q2 2026.
  • Swiss Life Asset Management bought 122 Pediatrix Medical shares in Q2 2026, an estimated $2.78K.
  • Pediatrix Medical made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1226 holding.
  • Swiss Life Asset Management first reported a position in Pediatrix Medical in Q1 2017 and has held it in 5 quarters since.
  • Swiss Life Asset Management's Pediatrix Medical position peaked at $1.1M in Q1 2017.
  • 197 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.